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AbstrACt
Objective Non-communicable diseases (NCDs) impose a 
significant health and economic burden. This study aimed 
to assess the differential attendance patterns of public to 
different healthcare professionals and gauge the opinions 
of key stakeholders towards screening of NCDs by allied 
healthcare professionals.
Design Questionnaires were designed piloted and 
subsequently completed by key stakeholders. The results 
were analysed descriptively.
setting Public questionnaires were undertaken in a West 
Midlands transport station and Public Markets. High street 
dental and community pharmacy settings were selected 
via local clinical and research networks. Healthcare 
professionals were identified using professional networks 
and were emailed a web link to an online survey.
Participants 1371 members of the public, 1548 patients 
and 222 healthcare professionals (doctors general 
practitioner (GP), dentists general dental practitioner (GDP) 
and pharmacists) completed the questionnaires.
Outcome measures The outcome was to compare 
attendance patterns at GDP and GP practices to determine 
whether different populations were more likely to 
access different healthcare professionals, this included 
determining when patients were last screened for NCDs by 
their GP. Additionally, the willingness of patients to undergo 
the required intervention and the opinions of stakeholders 
regarding the concept of screening for the specified NCDs 
in general dental and community pharmacy settings were 
also explored.
results 12% of patients who reported seeing a GDP 
biannually reported that they had not had contact with 
a GP in the last year. Over 61% of the public reported 
attending a GDP biannually, of this group 48% reported 
having never had a check-up at the GP. All stakeholders 
surveyed were in broad support of the concept of allied 
health professionals undertaking screening for specific 
general health conditions.
Conclusions This study has established that allied 
healthcare professionals may have access to different 
cohorts of the population to GPs. If GDPs and pharmacists 
have access to patients who are not using healthcare 
services elsewhere, they may be ideally placed to risk 
assess, and where appropriate offer preventative advice 
and test for NCDs.
IntrODuCtIOn  
The prevalence of chronic, non-communi-
cable diseases (NCDs) is increasing world-
wide and their impact on the healthcare 
economy is substantial1–3 with 92% of older 
adults having at least one NCD and 77% 
having two NCDs.4 The increasing prevalence 
of NCDs is partly due to an ageing popula-
tion, and partly due to an increase in preva-
lence of shared risk factors among multiple 
NCDs, such as sedentary lifestyles, diets 
high in refined carbohydrates, smoking and 
strengths and limitations of this study
 ► The main strength of this study was the large sam-
ple size. In total 2919 questionnaires were returned 
by the public and patients with a further 222 health-
care professionals completing the questionnaires.
 ► The results of this study align closely with the find-
ings from studies in the UK and USA.
 ► In the UK, screening is controversial, National 
Institute for Health and Care Excellence guidelines 
exist on risk assessing and screening for type 2 di-
abetes mellitus, however, the UK National Screening 
Committee does not currently advocate screening 
for non-communicable diseases.
 o
n
 5 N
ovem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-024503 on 3 November 2018. Downloaded from 
2 Yonel Z, et al. BMJ Open 2018;8:e024503. doi:10.1136/bmjopen-2018-024503
Open access 
obesity. Furthermore, risk factors for NCDs contribute a 
significant economic burden, accounting for over 45% of 
total National Health Service (NHS) costs in the UK in 
2006–2007, at approximately £43 billion.5 
The National Institute for Health and Care Excellence 
(NICE) currently recommend that allied healthcare 
professionals, including community pharmacists and 
general dental practitioners (GDPs), should risk assess 
for type 2 diabetes mellitus (T2DM).6 For example, for 
T2DM data from the USA suggest that screening for 
T2DM in a dental setting is effective in identifying both 
prediabetes and diabetes.7–9 Early detection also led to 
the instigation of cost-effective lifestyle change measures, 
rendering a proportion of prediabetes patients normo-
glycaemic.10 A further survey from the USA showed that 
24% of people did not have contact with a general health-
care provider in 2008, yet 23% of those sampled did see a 
dentist in that year.11 Furthermore, UK government poli-
cies have been set out, actively encouraging dental profes-
sionals in the provision of general health promotion12 13 
as GDPs already deliver advice on diet and smoking cessa-
tion. It has been suggested that highly skilled primary 
healthcare professionals, such as pharmacists and dentists 
(GDPs), may develop new roles and work more closely 
with general practitioners (GPs) to create effective multi-
disciplinary teams and care pathways, and provide a wider 
range of services such as early detection of disease.14
The 2011 Pharmaceutical Group of the European 
Union survey showed that 98% of European patients can 
reach their nearest community pharmacy within 30 min, 
while 58% indicated that their closest community phar-
macy was within 5 min of their home. In addition, over 
the past four decades, there has been a move in pharmacy 
practice away from the traditional focus on dispensing 
towards a more patient-centred clinical role.15 UK policy 
and pharmacists’ professional organisations have stressed 
the potential of community pharmacists to extend their 
roles in patient care services to include services such as 
screening for NCDs. This role has been emphasised in 
policy papers calling for a wider use of community phar-
macists in primary patient care.16–18
The development of government policies and guide-
lines advocating the role of allied healthcare professionals 
in risk assessment, prevention programmes and risk iden-
tification for NCDs suggests that a collaborative approach 
to tackle the growing NCD burden is required. However, 
the opinions of members of the public, patients and rele-
vant healthcare professionals in this matter remain poorly 
explored.
Thus, the aim of this study was to collect preliminary 
data to provide insight into the differential attendance 
patterns of public and patients to different healthcare 
providers, and the perceptions of key stakeholders 
including members of the public, patients and health-
care providers (GPs, GDPs and pharmacists), regarding 
risk-targeted screening programmes in dental and 
pharmacy settings for specific NCDs (T2DM, cardio-
vascular disease (CVD), chronic kidney disease (CKD) 
and respiratory chronic obstructive pulmonary disease, 
COPD) known to incur a significant health and economic 
burden.
The choice of targeting particular diseases for screening 
is supported by the fact that:
1. Strong evidence suggests that the majority of patients 
with objective COPD are not aware of their condition, 
and this leads to a significant delay in diagnosis and 
potential treatment.19
2. Both T2DM and hypertension tend to be asymptomat-
ic and are usually not diagnosed until patients develop 
symptoms.20
3. Atrial fibrillation is a major treatable risk factor for 
stroke, but it may be hard for patients to self-detect, 
because it is frequently silent and intermittent21 22;
4. Early diagnosis of CKD and immediate referral are key 
steps in the management of CKD because this allows 
implementation of preventive measures that delay 
or even halt progression of CKD to end-stage renal 
disease.23
MAterIAls AnD MethODs
Patient involvement
The development of the research question was informed 
by discussions with an advisory group comprising senior 
dental and medical academics working in the fields of 
NCDs. The research question was then taken to patient 
focus groups and refined following discussions with 
patient and public advocates at a health awareness 
engagement event (AGEWELL).
Patients were involved in the design of the study 
through feedback and discussions relating to the ques-
tionnaire design.
Results will be disseminated through publication, 
presentation at conferences and returning to the annual 
AGEWELL engagement event to present findings.
Surveys
Questionnaires were developed that explored the atti-
tudes of the public, patients and registered healthcare 
professionals (GPs, GDPs and pharmacists). Data were 
collected on attendance with healthcare professionals, 
participant demographics and their opinions on having 
general health checks in the specified setting.
No personal identifiers were collected.
Public survey
To assess the views of members of the public, we 
conducted surveys in two different settings, Birmingham 
New Street Railway Station (n=909) and Birmingham 
Public Markets (n=462), between June and September 
2016. There was no predefined target sample size; 
instead, 6 days were spent at each site with an aim to 
recruit as many participants as possible. Potential 
participants were informed about the study and offered 
a patient information sheet, information posters were 
displayed explaining the study. Participants who verbally 
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consented to participate were then asked to complete 
the electronic questionnaire on a tablet computer 
(figure 1).
In addition to basic demographic data, including age, 
ethnicity, gender and occupational status, questions were 
asked regarding last attendance with a GP and last time 
a GP surgery was visited for a check-up (ie, not due to 
an acute health concern). Participants were also asked 
whether they are registered with a dentist, whether they 
see a dentist for a routine check-up and, if so, at what 
frequency. In addition, participants were also asked 
whether they felt general health problems should be 
‘screened’ for in a dental or pharmacy setting. Partic-
ipants were asked their opinions regarding screening 
for specific conditions including hypertension, diabetes, 
lung health and kidney health, on a 5-point Likert scale. 
Similarly, patients were asked to rate their willingness to 
undergo a finger-prick capillary blood test, urine test or 
complete a questionnaire for screening purposes. These 
questions were asked separately for screening in dental 
practice and for a community pharmacy setting.
Patient surveys
To assess the views of patients, surveys were conducted 
in dental practices and pharmacies. Patients were iden-
tified from 13 NHS dental practices in England (n=515) 
and a private dental practice in Scotland (n=500) and 
25 community pharmacies in England (n=533). Similar 
to the public questionnaires, information posters were 
displayed explaining the study. Patients were told about 
the study and offered a patient information sheet. If 
patients verbally consented to participate, a paper ques-
tionnaire was made available for them to complete and 
return to the practice staff. Content and format of the 
patient questionnaire was similar to that of the public 
questionnaire.
Professional surveys
To determine the views of healthcare professionals, GPs 
(n=48), GDPs (n=129) and pharmacists (n=45) were 
contacted by email via known professional networks 
including the clinical research networks. The email 
contained a participant information sheet and elec-
tronic link to the online questionnaire. The question-
naire requested participants to disclose their occupation 
and whether they worked on a private, NHS or mixed 
(both private and NHS) basis. The respondent was 
also asked their opinion regarding dentists and phar-
macists screening for specified NCDs (hypertension, 
diabetes, CKD, COPD). The survey also determined 
whether professionals felt it would be appropriate for a 
suitably trained member of the dental/pharmacy team 
to perform finger-prick capillary blood tests, question-
naires or urinalysis on patients to obtain the relevant 
biomarker information. Further to this, demographic 
data in terms of age, gender, location of practice were 
also recorded.
Figure 1 Public questionnaire. REDCap, Research 
Electronic Data Capture.
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Analysis
Summary statistics were calculated using Stata/IC V.12.1 
(StataCorp LP).
Data sharing statement
Pseudonymised individual participant data, used in prepa-
ration for this manuscript, will be available immediately 
following publication for a period of 36 months. This will 
be available to researchers providing a methodologically 
sound proposal and for the purposes of achieving the 
aims of that proposal only. Proposals should be directed 
to the corresponding author. To gain access, researchers 
will need to sign a data access agreement.
results
In total, 2919 public and patient questionnaires were 
returned in this study: Birmingham New Street railway 
station, (n=909), Birmingham Public Markets (n=462). 
Patient questionnaires were completed in NHS dental 
(n=515), private dental (n=499) and pharmacy (n=533) 
settings (table 1).
Public questionnaires
Attendance
Twenty-two per cent of respondents at New Street railway 
station and 26% at Birmingham Public Markets reported 
they had not had any contact with their GP within the 
preceding 12 months. Almost 10% of the public reported 
not having seen a GP in at least 5 years (table 2).
Twenty-six per cent of respondents at New Street 
station and 31% at Birmingham Public Markets reported 
attending their GP surgery for a routine check-up and 
not due to an acute illness within the last 12 months. 
Respondents in public settings were less likely to attend 
a GP surgery for a routine check-up compared with those 
patients attending dental or pharmacy settings (table 2).
Seventy-seven per cent of respondents at Birmingham 
New Street railway station and 61% at the Birmingham 
Public Markets reported being registered with a dentist. 
When asked about attendance pattern with a dentist, the 
most frequently reported appointment interval for both 
public settings was 6 monthly (table 3).
When comparing attendance of members of the public 
at their GP or their GDP, 12% of patients who reported 
Table 1 Demographics of public and patient respondents (figures presented as percentage unless otherwise stated)
No of questionnaires 
returned
Public opinion Patient opinion
New Street 
railway station
Birmingham 
Public Markets
NHS dental 
patients
Private dental 
patients
Pharmacy 
patients
n=909 n=462 n=515 n=500 n=533
Gender
  Male 52 40 38 38 37
Age in years
  18–29 24 22 22 8 15
  30–39 15 16 25 12 17
  40–49 15 16 20 20 23
  50–59 17 15 17 23 19
  60–69 15 17 11 25 14
  >70 15 15 5 12 12
Ethnicity
  White/Caucasian 78 34 73 97 83
  Asian 6 23 22 1 8
  Afro-Caribbean 6 35 3 1 4
  Mixed 5 4 2 0 5
  Other 4 4 0 1 0
Occupation
  Unemployed 9 31 18 3 14
  Manual Worker 7 16 15 10 16
  Non-manual worker 16 12 13 12 12
  Executive/managerial 12 3 10 17 8
  Professional 31 11 30 23 24
  Retired 25 27 14 34 25
NHS, National Health Service.
 o
n
 5 N
ovem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-024503 on 3 November 2018. Downloaded from 
5Yonel Z, et al. BMJ Open 2018;8:e024503. doi:10.1136/bmjopen-2018-024503
Open access
seeing a GDP every 6 months reported that they had not 
had contact with a GP in the last year. Furthermore, of the 
public respondents that reported being regular dental 
attenders 48% reported having never had a health check 
at their GP surgery. An additional 20% of the public who 
reported being regular dental attenders claimed to have 
not attended a GP practice for a routine check-up in the 
last 12 months and of the 48% that reported having never 
had a check-up at the GP surgery 61% reported attending 
a dental practice biannually.
Opinions
Public support for screening for medical conditions in 
both dental and pharmacy settings was strong, with 74% 
in favour of screening in dental settings and 70% in favour 
of screening in pharmacy settings. The conditions that 
most public respondents were in support of screening 
for were T2DM and hypertension in both dental and 
pharmacy settings. The public expressed willingness to 
undergo each of the proposed interventions (urinalysis, 
finger-prick capillary blood) in both settings with a slight 
preference for the dental setting.
Patient questionnaires
Attendance
Twenty-eight per cent of respondents at NHS GDP 
settings, 25% of respondents at private GDP settings and 
17% of patients at pharmacies reported they have not 
had any contact with their GP within the last 12 months. 
Seven per cent of respondents at NHS GDP settings, 5% 
of respondents at private GDP settings and 3% at phar-
macies reported having not seen a GP in at least 5 years.
Forty-six per cent of respondents at NHS GDP settings, 
57% of respondents at private GDP settings and 51% at 
the pharmacies reported attending their GP surgery for a 
routine check-up within the last 12 months.
Patients attending dental or pharmacy settings were 
more likely to attend a GP surgery for a routine check-up 
compared with those in public settings. Those patients 
attending a pharmacy were not asked about dental atten-
dance. When those attending dental practices were asked 
about attendance patterns the most frequently reported 
appointment interval was 6 monthly.
When comparing attendance of NHS dental patients at 
GP and GDP practices, of the 28% of NHS dental patients 
who reported they had not had any contact with their GP 
within the last 12 months, 42% were in favour of having 
NCD screening at their GDP. When comparing the atten-
dance of private dental patients at GP and GDP practices, 
of the 25% of private dental patients who reported they 
had not had any contact with their GP within the last 12 
months, 65% were in favour of having NCD screening 
at their GDP practice. When comparing attendance of 
pharmacy patients at GPs and pharmacies, of the 17% of 
pharmacy patients who reported they had not had any 
contact with their GP within the last 12 months 32% were 
Table 2 Comparison of attendance patterns to general practitioner (GP) practices for the public and those attending 
pharmacy and dental practices (figures presented as percentage unless otherwise stated)
Public opinion Patient opinion
New Street 
railway station
Birmingham 
Public Markets
NHS dental 
patients
Private dental 
patients
Pharmacy 
patients
n=909 n=462 n=515 n=500 n=533
When did you last visit your GP?
  Less than 1 year ago 78 74 71 75 83
  More than 1 year ago 17 20 22 20 14
  More than 5 years ago 5 4 7 5 3
  Never 0 3 n/a n/a n/a
When did you last visit your GP for a routine health check?
  Less than 1 year ago 26 31 47 43 48
  More than 1 year ago 16 24 22 22 23
  More than 5 years ago 6 6 28 34 6
  Never 52 39 3 2 24
NHS, National Health Service.
Table 3 Comparison of the reported frequency of dental 
check-ups, for those members of the public who reported 
that they attended a dentist (general dental practitioner) 
regularly
If you are a regular dental attender at what 
frequency do you attend the dentist for 
check-up appointments?
New 
Street (N)
New 
Street (%)
Public 
Market (N)
Public 
Market 
(%)
3 monthly 67 9 28 10
6 monthly 479 67 177 63
12 monthly 138 19 71 25
Other 33 5 6 2
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in favour of having NCD screening at their community 
pharmacy.
Opinions
Forty-eight per cent of NHS dental patients either 
strongly agreed or agreed with the concept of screening 
for NCDs in dental settings. Sixty-one per cent of private 
dental patients either strongly agreed or agreed with the 
concept of screening for NCDs in dental settings. Seven-
ty-five per cent of pharmacy patients were in support of 
screening for NCDs in pharmacy settings. The condi-
tions that most of the public and patients were in support 
of screening for were T2DM and hypertension in both 
dental and pharmacy settings.
Healthcare professionals
In total 222 completed questionnaires were returned, of 
those returned 48% were completed by female healthcare 
professionals; 58% had been completed by GDPs, 21% 
by GPs and the remainder by community pharmacists. 
More than half (51%) of those questioned were treating 
patients within NHS settings, 34% reported working on a 
mixed NHS and private basis and 15% reported working 
on a solely private basis (table 4).
Most GDPs were in favour of risk assessment in a phar-
macy setting. A large proportion of GPs and pharma-
cists were supportive of risk assessment in dental settings 
(figure 2), but many remained undecided. There was 
stronger support from healthcare professionals for 
risk assessment for NCDs in pharmacy settings (figure 3).
DIsCussIOn
statement of principle findings
This study aimed to determine the attendance patterns of the 
public at different healthcare settings and to gauge public 
and patient opinions on using allied healthcare profes-
sionals to undertake ‘screening’. Participants were more 
likely to attend their dental practice for a routine check-up 
than their GP surgery. Of those patients who reported being 
regular attenders to a dental surgery for routine check-ups, 
almost half claimed that they had ‘never’ had a routine 
health-check at their GP surgery. Furthermore, an additional 
26% had not had a routine check at the GP practice in more 
than 12 months. This implies that dental professionals have 
access to a cohort of patients who are not routinely accessing 
their GP surgery for health checks.
Table 4 Demographic data of healthcare professional 
respondents (figures expressed as percentage unless 
otherwise stated)
No of questionnaires returned
General 
practitioner
General dental 
practitioner Pharmacist
n=48 n=129 n=45
Gender
  Male 21 61 18
  Female 79 39 82
Age in years
  18–29 6 23 36
  30–39 21 18 38
  40–49 44 26 9
  50–59 25 26 11
  60–69 4 6 6
  70+ 0 1 0
Funded
  National Health Service (NHS) 94 38 51
  Private 0 13 15
  Mixed (NHS and Private) 6 48 33
Figure 2 Showing professional opinion to screening in dental practice expressed as a percentage. GDP, general dental 
practitioner; GP, general practitioner; NCDs, non-communicable diseases.
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All stakeholders surveyed were in broad support of the 
concept of allied professionals undertaking risk assess-
ment for general health conditions. The public were 
slightly more in favour for risk assessment in dental 
compared with pharmacy settings, whereas health-
care professionals expressed slightly greater support 
for risk assessment in pharmacy compared with dental 
settings. The conditions receiving the greatest support 
for risk assessment were T2DM and CVD. The methods 
for risk assessing that were mostly accepted were validated 
questionnaires and finger-prick capillary blood testing.
strengths and weaknesses of the study
The main strength of this study was the large sample size. 
In total 2919 questionnaires were returned by public 
and patients with a further 222 healthcare professionals 
completing the questionnaires. However, the population 
captured was not representative of the UK population as 
a whole and caution should be applied in relating find-
ings to the general population. The sampling method 
used did not allow for calculation of a response rate. 
Thus, potential bias cannot be ruled out. The NHS dental 
and pharmacy respondents were the most likely to have 
attended their GP practice for a routine check-up, with 
respondents in both public settings being the least likely 
to attend a GP surgery for a routine check-up. This may 
suggest that those patients already engaged with health-
care are more likely to take up any proposed risk assess-
ment, should a new service become available. This finding 
may limit the value of any such service as those in most 
need of early identification, who are not in contact with a 
GP are also the group least likely to contact other health-
care professionals.
strengths and weaknesses in relation to other studies
Health screening in the UK is controversial, although 
NICE guidelines exist on risk assessing and screening 
for T2DM, the UK National Screening Committee (UK 
NSC) currently does not advocate screening for T2DM 
or the other mentioned NCDs. Despite the current UK 
NSC position on screening, when asked whether they felt 
screening for NCD in dental and pharmacy settings was 
worthwhile most healthcare professionals were supportive 
of this in both settings.
The results of this study align closely with the find-
ings of Greenberg’s study in the USA, which reported 
that dentists were in support of chairside screening 
for medical conditions and were willing to undertake 
the screening procedures.24 Creanor et al undertook 
a similar study in the UK whereby patients attending 
dental clinics in the Southwest of England were asked 
about diabetes screening. They found that 61% of 
respondents had never knowingly been screened for 
diabetes, 87% were in support of screening for medical 
conditions such as diabetes at the dental clinic.25 This 
was further supported by a study in Warwickshire where 
adult patients with diabetes attending medical clinics 
were asked about screening for diabetes in dental 
settings. Bowyer et al reported that over half of respon-
dents supported the idea of dentists’ involvement in 
diabetes screening.26
Furthermore, a study by Bould et al found that the 
uptake of risk assessment methods for diabetes in dental 
settings was positive, patients were amenable to finger-
prick testing and when a two-stage screening process was 
employed (validated questionnaire prior to finger-prick 
test) patients were three times as likely to follow-up with 
Figure 3 Showing professional opinion to screening in pharmacy expressed as a percentage. GDP, general dental practitioner; 
GP, general practitioner; NCDs, non-communicable diseases. 
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their GP compared with those receiving only one positive 
result.27
In a recent review of community pharmacy clinical 
services Murray 2016 (PSNC, 2016) concluded that 
community pharmacists should develop interventions to 
further prevent disease progression. Previous evidence 
from systematic reviews and meta-analyses has shown 
that community pharmacies could be feasible sites for 
screening for isolated risk factors.28 29 Screening for indi-
vidual risk factors in pharmacies has been shown to be 
effective, in studies in the UK30 and in countries outside 
the UK.31 32 Furthermore, UK public health initiatives 
have been previously tested in pharmacies and claimed 
some success, such as healthy living pharmacies (public 
health-related services) and health checks (cardiovas-
cular risk assessment). However, further research is 
needed to determine the uptake of pharmacy recom-
mendations and referrals following the screening and the 
cost-effectiveness of screening in pharmacies compared 
with screening from other providers.
Meaning of the study
The choice to seek public, patient and professional opin-
ions for using allied health professionals to undertake 
proactive targeted risk assessment to the specific NCDs 
was based on the significant health and economic burden 
that NCDs have on individuals and society as a whole.33
Utilisation of allied healthcare professionals would be 
particularly interesting if different healthcare providers 
could reach/access different population groups. Our 
surveys demonstrated that, of those patients who reported 
being regular attenders to a dental surgery for routine 
check-ups, almost half of patients claimed that they had 
‘never’ had a routine health check at their GP surgery. 
Furthermore, an additional quarter of those surveyed had 
not had a routine check at their GP practice in more than 
12 months. This may indicate that dental professionals 
have access to a cohort of patients who are not routinely 
accessing their GP surgery for health checks. However, 
there is a possibility that many GPs use appointments 
that were not necessarily booked with health checks in 
mind to offer opportunistic risk assessment to patients 
they deem high risk. Thus, patients were also asked about 
general attendance at GP surgeries, and of those respon-
dents who reported attendance at a dental practice within 
12 months, 21% claimed to have not attended their GP 
practice within the same period. Therefore, this still 
suggests a potential missed opportunity for risk assess-
ment and preventative advice as one in five patients 
attending dentists have not had contact with a GP prac-
tice within that year.
Our findings support the concept that many people 
only attend their GP when they are unwell, whereas by 
contrast, they may visit allied health professionals on a 
regular basis, even when asymptomatic. With longer 
opening hours for pharmacies and easy accessibility to 
dental practices, this potentially places dental teams and 
community pharmacists in an ideal position to target 
patients for risk assessment and health screening, espe-
cially for those who may not visit their GP regularly.
Many pharmacies already successfully offer screening 
programmes for a variety of conditions. This may be an 
opportunity to broaden the scope of this service further 
and given that opinions of stakeholders are compa-
rable across the settings assessed and screening can be 
performed to good effect in pharmacy settings, it may 
be of benefit to explore this concept further in dental 
settings.
unanswered questions and future research
The reported study has shown that key stakeholders are 
in broad support of greater utilisation of allied profes-
sionals in the early risk assessment and detection of NCDs. 
Further work is needed to determine feasibility of imple-
mentation of these principles and to establish whether the 
opinions translate into uptake of the service by patients 
and the public. It is also important to determine whether 
long-term intervention by allied professionals’ results 
in improved outcomes in patient care and whether that 
also conveys any health economic benefits. Furthermore, 
consideration must be given to how such a service would 
be funded as it is unlikely that healthcare professionals 
will undertake this risk assessment under existing funding 
arrangements. Therefore, health economic analysis will 
need to be undertaken to determine the cost savings 
to the NHS, or wider society and whether these savings 
can be used to fund the risk assessment. Another option 
may be exploring patients’ willingness to pay for such 
risk assessment. Future exploratory work to determine 
whether allied healthcare professionals would be willing 
or able to conduct such methods of targeted early detec-
tion of NCDs within existing funding arrangements must 
be considered. Likewise, whether patients would be 
willing to pay an additional fee or contribution for such a 
service would need to be determined.
COnClusIOn
The four key players in the NCD global challenge are 
CVD, respiratory disease, diabetes and cancer. It has been 
established that allied healthcare professionals may have 
access to different cohorts of the population and those 
members of society less likely to visit a GP may be more 
likely to visit a community pharmacy or general dentist. It 
is therefore possible that if dentists and pharmacists have 
access to patients who are not using healthcare services 
elsewhere, they may be ideally placed to risk assess, and 
where appropriate offer preventative advice and test for 
NCDs. In the dental clinic, this may be especially perti-
nent where those NCDs share common risk factors and 
associations with primary dental diseases, such as peri-
odontal disease, for which prevention strategies are 
already established.
Increased collaboration between general medical 
practitioners and allied healthcare professionals to stem 
the rise in NCDs, by assisting with early identification, 
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provision of preventative advice and where appropriate, 
targeted risk-based identification of disease, may prove 
beneficial to patients’ general health and oral health 
alike. The results from this survey suggest that all stake-
holders appear to be largely supportive of potential 
risk identification services for NCDs, especially diabetes 
and CVD in both dental and pharmacy settings.
Author affiliations
1Periodontal Research group, School of Dentistry, University of Birmingham and 
Birmingham Community Healthcare NHS Foundation Trust, Birmingham, UK
2School of Pharmacy, University of Birmingham, Birmingham, UK
Contributor Substantial contributions to the conception or design of the work or 
the acquisition, analysis or interpretation of data for the work: ZY, PS, AY, ZJ, ILC and 
TD. Drafting the work or revising it critically for important intellectual content: ZY, 
PS, ZJ, TD and ILC. Final approval of the version to be published: ILC. Agreement 
to be accountable for all aspects of the work in ensuring that questions related to 
the accuracy or integrity of any part of the work are appropriately investigated and 
resolved. ZY.
Funding This work was supported by a grant from the Oral and Dental Research 
Trust. NIHR Portfolio number (CPMS ID 32232).
Competing interests ILC acts as a consultant to Oral Health Innovations who 
provide PreViser and DEPPA risk and disease assessment technologies for dental 
practices. The other authors of this article have no conflicts of interest to declare. 
Patient consent Obtained.
ethics approval All surveys were approved by the National Research Ethics 
Service (NRES 16/YH/0293) or the Ethics Committee of the University of 
Birmingham (RG_15–195). 
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Pseudonymised individual participant data, used in 
preparation for this manuscript, will be available immediately following publication 
for a period of 36 months. This will be available to researchers providing a 
methodologically sound proposal and for the purposes of achieving the aims of that 
proposal only. Proposals should be directed to the corresponding author. To gain 
access, researchers will need to sign a data access agreement.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. Muka T, Imo D, Jaspers L, et al. The global impact of non-
communicable diseases on healthcare spending and national 
income: a systematic review. Eur J Epidemiol 2015;30:251–77.
 2. Engelgau M, Rosenhouse S, El-Saharty S, et al. The economic effect 
of noncommunicable diseases on households and nations: a review 
of existing evidence. J Health Commun 2011;16 :75–81.
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